Keyphrases
Absolute Lymphocyte Count
11%
Adjusted Odds Ratio
11%
Allergy Disease
18%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
14%
Baricitinib
14%
Clinical Trial Data
7%
Clinically Significant
7%
Confidence Interval
16%
Coronavirus Disease (COVID)
12%
COVID-19
100%
COVID-19 Outcomes
7%
COVID-19 Pandemic
14%
COVID-19 Treatment
19%
Disease Stage
7%
Disease Threat
7%
Doxycycline
7%
Emerging Infectious Diseases
8%
Guideline Dissemination
7%
Hazard Ratio
9%
Hospitalized Adults
22%
Immunomodulator
10%
Infectious Diseases
21%
Influenza
25%
Influenza-like Illness
7%
Invasive Mechanical Ventilation
9%
Lessons Learned
7%
Meta-analysis
14%
Meta-analysis of Randomized Controlled Trials
7%
Monoclonal Antibody
11%
Multilineage
7%
National Institutes of Health
8%
Nursing Homes
9%
Pandemic Influenza Virus
7%
Placebo
15%
Placebo-controlled Trial
7%
Randomized Controlled Trial
12%
Randomized Placebo-controlled Trial
10%
Remdesivir
56%
Respiratory Syncytial Virus
7%
Risk Profile
9%
SARS-CoV-2 Infection
11%
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
8%
Severe COVID-19
15%
Severe Disease
8%
Systematic Meta-analysis
14%
Therapeutic Landscapes
7%
Treatment Algorithm
7%
Treatment Trials
32%
Underuse
7%
Universal Vaccine
14%
Pharmacology, Toxicology and Pharmaceutical Science
Baricitinib
28%
Biological Marker
7%
Clinical Trial
8%
Coronavirinae
26%
Corticosteroid
7%
COVID-19 Vaccine
7%
Dexamethasone
10%
Diseases
51%
Doxycycline
7%
Immunocompromised Patient
8%
Immunomodulating Agent
12%
Infection
39%
Live Attenuated Influenza Vaccine
7%
Multiple Myeloma
7%
Observational Study
8%
Pandemic
21%
Placebo
29%
Quinolone Derivative
7%
Randomized Controlled Trial
19%
Remdesivir
49%
Respiratory Tract Infection
6%
Respiratory Virus
7%
SARS Coronavirus
33%
Secondary Infection
10%
Sudden Infant Death Syndrome
7%
Therapeutic Use
7%
Tolerability
7%
Medicine and Dentistry
Artificial Respiration
7%
Cell Transplantation
7%
Corticosteroid
7%
COVID-19
57%
COVID-19 Vaccine
14%
Cyclophosphamide
7%
Cytopenia
7%
Diseases
9%
Emerging Infectious Disease
7%
Graft Failure
7%
Heart Rate Variability
5%
Heart Surgery
7%
Hematopoietic Cell
7%
Immunocompromised Patient
7%
Immunomodulating Agent
7%
Infection
30%
Infectious Disease
15%
Influenza A Virus
7%
Influenza Vaccine
14%
Lymphocyte
7%
Lymphocytopenia
7%
Meta-Analysis
21%
Mycobacterium Chimaera
7%
Observational Study
8%
Odds Ratio
11%
Pandemic
7%
Post-Hoc Analysis
7%
Primary Prevention
7%
Randomized Controlled Trial
9%
Remdesivir
7%
Severe Acute Respiratory Syndrome Coronavirus 2
13%
Splenomegaly
7%
Sudden Infant Death Syndrome
7%
Systematic Review
14%
Transplantation
7%
Wearable Sensor
7%